Company intelligence / Profile preview

Hebei Longhai Pharmaceutical Co. Ltd.

Ownership: Private
Development stage: Commercial

Overview

Hebei Longhai Pharmaceutical Co. Ltd. is a private pharmaceutical company based in Hebei, China, established in 1998. The company focuses on the development and manufacturing of generic drugs, with multiple products having completed bioequivalence studies and being commercially available in China[1]. Clinical results include successful completion of at least two major bioequivalence trials for acetylcysteine effervescent tablets and bisoprolol amlodipine tablets[1].

Therapeutic areas: PulmonologyCardiovascular
Modalities: Small molecules
Industry: Biotech

Drug pipeline

1 asset

amlodipine + benazepril

Commercial

Indications: Hypertension

Beyond the preview

Go deeper on Hebei Longhai Pharmaceutical Co. Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hebei Longhai Pharmaceutical Co. Ltd..

Explore the full profile